Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,665 | -10,656 | -43,543 | -30,940 | -21,762 |
| Depreciation Amortization | 431 | 218 | 859 | 639 | 416 |
| Other Working Capital | 462 | 2,160 | -642 | -2,713 | 104 |
| Other Operating Activity | 2,045 | 1,016 | 4,250 | 2,065 | 1,387 |
| Operating Cash Flow | $-17,727 | $-7,262 | $-39,076 | $-30,949 | $-19,855 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 576 | 576 | 298 | -38 | -1,695 |
| PPE Investments | -151 | -10 | -4,667 | -2,632 | -2,613 |
| Other Investing Activity | -1,435 | -1,206 | -4,932 | -2,450 | 0 |
| Investing Cash Flow | $-1,010 | $-640 | $-9,301 | $-5,120 | $-4,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 268 | 161 | 35,059 | 35,030 | 35,030 |
| Financing Cash Flow | $268 | $161 | $35,059 | $35,030 | $35,030 |
| Exchange Rate Effect | 19 | -8 | -829 | 528 | 368 |
| Beginning Cash Position | 39,246 | 39,246 | 53,393 | 53,393 | 53,393 |
| End Cash Position | 20,796 | 31,497 | 39,246 | 52,882 | 64,628 |
| Net Cash Flow | $-18,450 | $-7,749 | $-14,147 | $-511 | $11,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,727 | -7,262 | -39,076 | -30,949 | -19,855 |
| Capital Expenditure | -151 | -10 | -4,667 | -2,632 | -2,613 |
| Free Cash Flow | -17,878 | -7,272 | -43,743 | -33,581 | -22,468 |